You are subscribed to the Drug Topics Hospital Pharmacists' Report.

Drug Topics Hospital Pharmacists' Report

eNewsletter Subscribe

Print Subscribe

Digital Edition Subscribe

November 13, 2014

Web Version  |  Digital Edition  |  Share with a colleague

Facebook Like   Twitter Tweet

TODAY'S HEADLINES

Cigna agrees to lower HIV/AIDS drug costs for Floridians

Cigna Health and Life Insurance Co. has agreed to provide some lower-cost drugs for HIV/AIDS patients in Florida who sign up for health insurance coverage for 2015. » More

Pharmacist elected to Congress

State Sen. Buddy Carter, R-Pooler, recently became the only pharmacist in Congress when voters from Georgia's First Congressional District selected him as their representative. » More

Combination drug therapy approved for hepatitis C

FDA has approved simeprevir in combination with sofosbuvir as an oral, interferon- and ribavirin-free treatment option for genotype 1 chronic hepatitis infection in adults. » More

Antibacterial for gram-positive infections approved

Dalbavancin is the first drug to receive FDA approval as a qualified infectious disease product, a designation granted because dalbavancin is intended to treat serious or life-threatening infections. » More

Continuing Education

MTM essentials for weight management

This month's CE activity is part of a year-long CPE series, Medication Therapy Management Considerations for Adult Patients with Cardiovascular Disease. From February 2014 through January 2015, pharmacists can earn up to 24 hours of CPE credit with 12 monthly knowledge-based activities from the University of Connecticut School of Pharmacy and Drug Topics.

The goal of this month's activity is to educate pharmacists about the prevalence, health consequences, and nonpharmacologic and pharmacologic treatment options for obesity, with a focus on the recommendations made in the 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults.

To read and print the article with TEST QUESTIONS, click here.To proceed to the online exams and earn up to 2 CPE credits, click here to log in with the session code 14DT12-FKX42.

Announcement: Our CE activities have moved to a new learning management system to better serve you. The login to the Online CE Center is https://web2.uconn.edu/pharmacyce/login.php. All current user registration information has been uploaded for your convenience. Current users do not need to register. To review your registration page to ensure the data is up to date or to register, go to https://web2.uconn.edu/pharmacyce/program_register.php For a full list of courses, go to http://pharmacy.uconn.edu/academics/ce/drug-topics-and-uconn-ce/.

 

Check these out, too

Clarification on Nov. 4 Special Report

New treatment for advanced gastric cancer

North Dakota keeps pharmacy-ownership law

Flublok influenza vaccine approved

Voices

Anticoagulation Update

JP at Large

View from the Zoo

Viewpoints

Regulatory and Legal

Meetings and Events

 
Powered by Modern Medicine Advanstar Medical Communications Group